ftInvstr
SYMBIOTEC · Healthcare ₹1546.2 -3.24%
← Search another stock

SYMBIOTEC

Healthcare Drug Manufacturers - General
★ Watchlist ⧉ Add to bucket
₹1546.2
-3.24% today · 30d +42.31%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for SYMBIOTEC. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹280 Cr
NET PROFIT
₹52 Cr
OPM
32.72%
EPS
₹8.2
PE 77.36
◇ Sector Position
PEERPEROCE %
SYMBIOTEC77.36—
GLAXO40.0557.97
RUBICON90.2127.36
PFIZER20.9324.29
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
50
SCORE / 100
Overall
6-axis composite of the sections below.
Performance — —
Valuation STRETCHED 20
Growth STEADY 60
Profitability HIGH 90
Technicals NEUTRAL 52
Risk ELEVATED 30
Key Stats
TTM PE
77.36
P/B
8.4
52W HIGH
₹1628.0
OFF HIGH
-5.02%
DIV YIELD
0.0%
◉ Active Signals
MACDBullish33.2676
RSI(14)Bearish71.32
Street Consensus
3 analysts
₹1530.67
mean target
Low ₹1430.0Now ₹1546.2High ₹1622.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SYMBIOTEC and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.